Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISV-303 dosing in post-cataract surgery
NCT01190878Phase 2Completed
- Sponsor
- Sun Pharma
- Start
- Aug 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of bromfenac sodium in ocular inflammation, sponsored by Sun Pharma. Started Aug 2010; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT01190878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01190878.